Cargando…
Increased sialylation of site specific O-glycoforms of hemopexin in liver disease
BACKGROUND: Non-invasive monitoring of liver disease remains an important health issue. Liver secreted glycoproteins reflect pathophysiological states of the organ and represent a rational target for serologic monitoring. In this study, we describe sialylated O-glycoforms of liver-secreted hemopexin...
Autores principales: | Sanda, Miloslav, Benicky, Julius, Wu, Jing, Wang, Yiwen, Makambi, Kepher, Ahn, Jaeil, Smith, Coleman I., Zhao, Peng, Zhang, Lihua, Goldman, Radoslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034550/ https://www.ncbi.nlm.nih.gov/pubmed/27688741 http://dx.doi.org/10.1186/s12014-016-9125-x |
Ejemplares similares
-
A Rapid LC-MS/MS-PRM Assay for Serologic Quantification of Sialylated O-HPX Glycoforms in Patients with Liver Fibrosis
por: Panigrahi, Aswini, et al.
Publicado: (2022) -
A multiplexed microflow LC–MS/MS-PRM assay for serologic quantification of IgG N- and HPX O- glycoforms in liver fibrosis
por: Panigrahi, Aswini, et al.
Publicado: (2023) -
Quantification of Fucosylated Hemopexin and Complement Factor H in Plasma
of Patients with Liver Disease
por: Benicky, Julius, et al.
Publicado: (2014) -
Protein and Site Specificity
of Fucosylation in Liver-Secreted
Glycoproteins
por: Pompach, Petr, et al.
Publicado: (2014) -
Analysis of site and structure specific core fucosylation in liver cirrhosis using exoglycosidase-assisted data-independent LC-MS/MS
por: Sanda, Miloslav, et al.
Publicado: (2021)